Clinical Trials Directory

Trials / Completed

CompletedNCT02779361

Effect of Tea Consumption on Steroid Profile in Healthy Volunteers

Effect of Tea Consumption on Steroid Profile in Healthy Volunteers. Pilot Study

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Parc de Salut Mar · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Open label phase I clinical trial in healthy volunteers designed to assess changes on steroid profile after green tea consumption.

Detailed description

Anabolic androgenic steroids are included in the list of banned substances in sports by the World Anti-Doping Agency (WADA) because of its ability to improve the performance of athletes. Testosterone glucuronization by UGT2B17 isoenzyme (Uridine Diphosphate Glucuronyltransferase 2B17) is inhibited in vitro by green tea flavonols like epicatechin, epigallocatechin gallate (EGCG) and catechin gallate. Therefore a diet rich in green tea could interfere in androgens' glucuronization and cause a change on the steroid profile of the athletes that could be considered a false positive. A clinical trial designed to assess changes on steroid profile in healthy volunteers after green tea consumption will be conducted. Subjects with different UGT2B17 genotype will be recruited (10 of each type: ins/ins, ins/del, del/del) to study if the genotype can modulate the results obtained. Urine samples obtained before and during 7 days of green tea consumption will be used to compare steroid profile. Blood samples will be also collected to assess EGCG pharmacokinetics.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGreen teaLipton pure green tea, 5 teas on the first 6 days, and 9 teas on the day 7. Teas will be ingested at 08:00 am, 10:30 am, 13:00 pm, 15:30 pm, 18:00 pm days 1-6, and 08:00 am (\*), 10:30 am, 13:00 pm (\*), 15:30 pm, 18:00 pm (\*), 20:30 pm on day 7. One bag of tea will be used to prepare the beverages with exception of some beverages on day 7 that will be prepared with two bags (\*).

Timeline

Start date
2016-01-01
Primary completion
2017-02-14
Completion
2017-02-14
First posted
2016-05-20
Last updated
2017-07-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02779361. Inclusion in this directory is not an endorsement.